Vor Historical Valuation

VOR Stock  USD 0.77  0.04  4.94%   
Some fundamental drivers such as market cap or Vor Biopharma enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Vor Biopharma valuation indicators such as Market Cap of 72.5 M or Working Capital of 0.0 to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Vor Biopharma's future value.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vor Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Vor Stock, please use our How to Invest in Vor Biopharma guide.

About Vor Valuation Data Analysis

Valuation is the financial process of determining what Vor Biopharma is worth. Vor Biopharma valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Vor Biopharma valuation ratios help investors to determine whether Vor Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vor with respect to the benefits of owning Vor Biopharma security.

Vor Biopharma Valuation Data Chart

As of 03/27/2025, Market Cap is likely to drop to about 72.5 M. In addition to that, Enterprise Value is likely to drop to about 24.8 M

Enterprise Value

Enterprise Value (or EV) is usually referred to as Vor Biopharma theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Vor Biopharma debt, but would also pocket its cash. Enterprise Value is more accurate representation of Vor Biopharma value than its market capitalization because it takes into account all of Vor Biopharma existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Additional Tools for Vor Stock Analysis

When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.